These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 2885824)
1. [Effects of aging and various pharmacologic agents on the brain energy metabolism in the course of post-hypoglycemic recuperation in the rat]. Villa RF; Pastoris O Presse Med; 1987 Jun; 16(23):1128-34. PubMed ID: 2885824 [TBL] [Abstract][Full Text] [Related]
2. [The influence of aging on cerebral energy metabolism following post-hypoglycemic recovery in the rat. Pharmacologic application]. Villa RF; Pastoris O J Pharmacol; 1986; 17(4):623-36. PubMed ID: 3560973 [TBL] [Abstract][Full Text] [Related]
3. Influence of aging and exogenous substances on cerebral energy metabolism in posthypoglycemic recovery. Benzi G; Pastoris O; Villa RF; Giuffrida AM Biochem Pharmacol; 1985 May; 34(9):1477-83. PubMed ID: 3922378 [TBL] [Abstract][Full Text] [Related]
4. Cerebral and cerebellar metabolic changes induced by drugs during the recovery period after profound hypoglycemia. Benzi G; Villa RF; Dossena M; Vercesi L; Gorini A; Pastoris O Farmaco Sci; 1984 Jan; 39(1):44-56. PubMed ID: 6705914 [TBL] [Abstract][Full Text] [Related]
5. Role of drugs in recovery of metabolic function of rat brain following severe hypoglycemia. Benzi G; Villa RF; Dossena M; Vercesi L; Gorini A; Pastoris O Neurochem Res; 1984 Jul; 9(7):979-92. PubMed ID: 6504232 [TBL] [Abstract][Full Text] [Related]
6. Effect of aging on cerebral cortex energy metabolism in hypoglycemia and posthypoglycemic recovery. Benzi G; Pastoris O; Villa RF; Giuffrida AM Neurobiol Aging; 1984; 5(3):205-12. PubMed ID: 6514106 [TBL] [Abstract][Full Text] [Related]
7. [Quantified electroencephalogram: value in the evaluation of therapy of cerebral aging]. Sebban C; Tesolin B; Guez D Presse Med; 1987 Jun; 16(23):1154-8. PubMed ID: 2885826 [TBL] [Abstract][Full Text] [Related]
8. Experimental approach of treatment of cerebral ischemia by a combination of raubasine and almitrine. Borzeix MG; Cahn J Arzneimittelforschung; 1987 May; 37(5):491-4. PubMed ID: 2887170 [TBL] [Abstract][Full Text] [Related]
9. [Psychometric evaluation of the effects of an almitrine-raubasine combination in the intellectual deterioration of aged subjects. A double-blind controlled trial versus placebo]. Rapisarda V; Azzaro E; Fichera G Presse Med; 1987 Jun; 16(23):1163-6. PubMed ID: 2885827 [TBL] [Abstract][Full Text] [Related]
10. Comparative effects of almitrine and raubasine, singly and in combination, on electroencephalographic activity in young and old rats. Sebban C; Tesolin B; Coulomb B; Berthaux P Exp Gerontol; 1989; 24(1):11-24. PubMed ID: 2707311 [TBL] [Abstract][Full Text] [Related]
11. Regional levels of glucose, amino acids, high energy phosphates, and cyclic nucleotides in the central nervous system during hypoglycemic stupor and behavioral recovery. Gorell JM; Dolkart PH; Ferrendelli JA J Neurochem; 1976 Nov; 27(5):1043-9. PubMed ID: 12170586 [TBL] [Abstract][Full Text] [Related]
12. Curative effect of an almitrine-raubasine combination in the postischemic syndrome following transient cerebral ischemia in dogs. Cahn R; Cahn J Pharmacology; 1988; 36(3):156-65. PubMed ID: 3368502 [TBL] [Abstract][Full Text] [Related]
13. [Metabolic and blood circulation evaluation of acute ischemic cerebral accident in humans using positron emission tomography]. Depresseux JC; Franck G; Van Cauwenberge H Presse Med; 1987 Jun; 16(23):1145-50. PubMed ID: 2885825 [TBL] [Abstract][Full Text] [Related]
14. [Effect of a tissue oxygenator (almitrine + raubasine) on the metabolism of 2,3-diphosphoglycerate of rabbits submitted by hypoxia]. Callis A; Dorance M; Magnan de Bornier B C R Seances Soc Biol Fil; 1980; 174(6):1006-9. PubMed ID: 6451260 [TBL] [Abstract][Full Text] [Related]
15. Role of synaptosomal enzymatic alterations and drug treatment in brain aging. Curti D; Benzi G Clin Neuropharmacol; 1990; 13 Suppl 3():S59-72. PubMed ID: 1965531 [TBL] [Abstract][Full Text] [Related]
16. Recovery period after profound hypoglycemia. Influence of some metabolic modulators on the cerebral endogenous substrate utilization. Benzi G; Villa RF; Dossena M; Vercesi L; Gorini A; Taglietti M; Pastoris O Farmaco Sci; 1984 May; 39(5):430-49. PubMed ID: 6734818 [TBL] [Abstract][Full Text] [Related]
17. A review of the EEG effects of the combination of almitrine and raubasine in animals and humans. Sebban C; Tesolin B; Schatz C; Malbezin M; Guez D Clin Neuropharmacol; 1990; 13 Suppl 3():S50-8. PubMed ID: 2093418 [TBL] [Abstract][Full Text] [Related]
18. [Comparison of the effects of almitrine, raubasine and 5023 SE on arterial oxygen desaturation during exercise]. Sebban C; Berthaux P Presse Med; 1983 Mar; 12(13):847-8. PubMed ID: 6220334 [TBL] [Abstract][Full Text] [Related]
19. [Pharmacological approach to a treatment of senescence and cerebrovascular deficiencies related to hypoxia. Application to 5023 SE]. Devissaguet M Presse Med; 1983 Mar; 12(13):823-9. PubMed ID: 6220330 [TBL] [Abstract][Full Text] [Related]
20. Neurologic and histologic evaluation of almitrine+raubasine (Duxil) in middle cerebral artery occlusion in cats. Chan P; Li Y; Zheng Z; Hu P; Sarbach SD; Guez D Eur J Pharmacol; 1993 Feb; 231(2):175-82. PubMed ID: 8453973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]